LEADER 01366oam  2200397 a 450 
001 9910703083903321
005 20230902161740.0
035   $a(CKB)3360000000454445
035   $a(OCoLC)794182367
035   $a(EXLCZ)993360000000454445
100   $a20120523d2009      ua             0
101 0 $aeng
135   $aurmn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aHeadache$b[electronic resource] $ehope through research /$fprepared by Office of Communiations and Public Liaison
210  1$aBethesda, MD :$cNational Institutes of Health, National Institute of Neurological Disorders and Stroke,$d[2009]
215   $a1 online resource (50 pages) $ccolor illustrations
225 1 $aNIH Publication ;$vNo. 09-158
300   $a"September 2009."
300   $aTitle from title screen (viewed on May 23, 2012).
410  0$aNIH publication ;$vno. 09-158.
517   $aHeadache
606   $aHeadache
606   $aHeadache$xTreatment$zUnited States
615  0$aHeadache.
615  0$aHeadache$xTreatment
712 02$aNational Institute of Neurological Disorders and Stroke (U.S.).$bOffice of Communications and Public Liaison.
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910703083903321
996   $aHeadache$9795958
997   $aUNINA